Cargando…
Cell-Free Biological Approach for Corneal Stromal Wound Healing
Corneal opacification is the fourth most common cause of blindness globally behind cataracts, glaucoma, and age-related macular degeneration. The standard treatment of serious corneal scarring is corneal transplantation. Though it is effective for restoring vision, the treatment outcome is not optim...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193853/ https://www.ncbi.nlm.nih.gov/pubmed/34122095 http://dx.doi.org/10.3389/fphar.2021.671405 |
_version_ | 1783706306715058176 |
---|---|
author | Jhanji, Vishal Billig, Isabelle Yam, Gary Hin-Fai |
author_facet | Jhanji, Vishal Billig, Isabelle Yam, Gary Hin-Fai |
author_sort | Jhanji, Vishal |
collection | PubMed |
description | Corneal opacification is the fourth most common cause of blindness globally behind cataracts, glaucoma, and age-related macular degeneration. The standard treatment of serious corneal scarring is corneal transplantation. Though it is effective for restoring vision, the treatment outcome is not optimal, due to limitations such as long-term graft survival, lifelong use of immunosuppressants, and a loss of corneal strength. Regulation of corneal stromal wound healing, along with inhibition or downregulation of corneal scarring is a promising approach to prevent corneal opacification. Pharmacological approaches have been suggested, however these are fraught with side effects. Tissue healing is an intricate process that involves cell death, proliferation, differentiation, and remodeling of the extracellular matrix. Current research on stromal wound healing is focused on corneal characteristics such as the immune response, angiogenesis, and cell signaling. Indeed, promising new technologies with the potential to modulate wound healing are under development. In this review, we provide an overview of cell-free strategies and some approaches under development that have the potential to control stromal fibrosis and scarring, especially in the context of early intervention. |
format | Online Article Text |
id | pubmed-8193853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81938532021-06-12 Cell-Free Biological Approach for Corneal Stromal Wound Healing Jhanji, Vishal Billig, Isabelle Yam, Gary Hin-Fai Front Pharmacol Pharmacology Corneal opacification is the fourth most common cause of blindness globally behind cataracts, glaucoma, and age-related macular degeneration. The standard treatment of serious corneal scarring is corneal transplantation. Though it is effective for restoring vision, the treatment outcome is not optimal, due to limitations such as long-term graft survival, lifelong use of immunosuppressants, and a loss of corneal strength. Regulation of corneal stromal wound healing, along with inhibition or downregulation of corneal scarring is a promising approach to prevent corneal opacification. Pharmacological approaches have been suggested, however these are fraught with side effects. Tissue healing is an intricate process that involves cell death, proliferation, differentiation, and remodeling of the extracellular matrix. Current research on stromal wound healing is focused on corneal characteristics such as the immune response, angiogenesis, and cell signaling. Indeed, promising new technologies with the potential to modulate wound healing are under development. In this review, we provide an overview of cell-free strategies and some approaches under development that have the potential to control stromal fibrosis and scarring, especially in the context of early intervention. Frontiers Media S.A. 2021-05-28 /pmc/articles/PMC8193853/ /pubmed/34122095 http://dx.doi.org/10.3389/fphar.2021.671405 Text en Copyright © 2021 Jhanji, Billig and Yam. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Jhanji, Vishal Billig, Isabelle Yam, Gary Hin-Fai Cell-Free Biological Approach for Corneal Stromal Wound Healing |
title | Cell-Free Biological Approach for Corneal Stromal Wound Healing |
title_full | Cell-Free Biological Approach for Corneal Stromal Wound Healing |
title_fullStr | Cell-Free Biological Approach for Corneal Stromal Wound Healing |
title_full_unstemmed | Cell-Free Biological Approach for Corneal Stromal Wound Healing |
title_short | Cell-Free Biological Approach for Corneal Stromal Wound Healing |
title_sort | cell-free biological approach for corneal stromal wound healing |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193853/ https://www.ncbi.nlm.nih.gov/pubmed/34122095 http://dx.doi.org/10.3389/fphar.2021.671405 |
work_keys_str_mv | AT jhanjivishal cellfreebiologicalapproachforcornealstromalwoundhealing AT billigisabelle cellfreebiologicalapproachforcornealstromalwoundhealing AT yamgaryhinfai cellfreebiologicalapproachforcornealstromalwoundhealing |